Top Healthcare Groups for exposure (overall)? (NYC)

Hi, hoping to see if anyone has insight or access to information that sheds insight on the top healthcare groups on the street? Are there certain firms that outperform in this area over others?

I understand there are various verticals and sectors in Healthcare and some firms may outperform others in that particular area but was hoping to see overall wise, which firms would be the strongest in the Healthcare space for an overall healthcare investment banking experience.

From research and previous threads it seems top groups HC overall:

1.) GS/JPM
2.) Barclays/BAML
3.) Citi
4.) MS
5.) CS
6.) DB/UBS

Middle Market/Boutique:
1.) Piper Jaffray
2.) PWP
3.) Jefferies
4.) Centerview

Would be great to see if anyone can shed insight on this or have any information.

WSO Elite Modeling Package

  • 6 courses to mastery: Excel, Financial Statement, LBO, M&A, Valuation and DCF
  • Elite instructors from top BB investment banks and private equity megafunds
  • Includes Company DB + Video Library Access (1 year)

Comments (34)

Jun 2, 2020 - 4:42pm

Your boutique stuff is lacking. CenterView is almost GS like in HC now. You are also excluding Lazard, Moelis,Evercore, Guggenheim who all probably do lot more than PWP. Jefferies and even Houlihan probably do more than Piper

  • 5
  • Intern in IB - Gen
Jun 2, 2020 - 6:36pm

I think Barclays is too high. Someone already mentioned this but add Gugg.

Check out the recent thread on here comparing Gugg and Barclays

Learn More

300+ video lessons across 6 modeling courses taught by elite practitioners at the top investment banks and private equity funds -- Excel Modeling -- Financial Statement Modeling -- M&A Modeling -- LBO Modeling -- DCF and Valuation Modeling -- ALL INCLUDED + 2 Huge Bonuses.

Learn more
  • Analyst 2 in IB - Cov
Jun 3, 2020 - 12:42am

Depends what you consider when you say overall healthcare investment banking experience. If you only mean M&A, which is not even close to an overall experience, then Centerview runs healthcare at the moment and it is not even close. They seem to be on every single large biotech sell side for the past 18+ months. If you want to work with clients through the entire process of healthcare, then you would be much better suited at a middle market bank that focuses on being an advisor at every stage. Healthcare is one of the more fragmented sectors in banking with much smaller firms generating substantial fees due to their specialty in the sector.

  • Intern in IB - Cov
Jun 8, 2020 - 6:36pm

do you know specifically which verticals within HC they do best in?

  • Intern in IB - Cov
Jun 8, 2020 - 6:35pm

He's not new, just an internal promotion but DB is very strong in HCIT and is able to edge out UBS in overall healthcare because of it.

  • Analyst 2 in IB-M&A
Jun 8, 2020 - 6:51pm

Your BB ranking is completely inaccurate.

MS is on par with GS / JPM. They were on AbbVie Allergan, BMS Celgene and countless other mega-deals. This makes me think you work at one of the banks listed as 2 and 3.

Jun 9, 2020 - 12:41am

Bunch of smaller boutiques and capital market-heavy shops out there that you didn't name that all do deals and therefore have solid experience in my opinion (I know people at most of these). Just to rattle off some that may or may not be named here in no particular order: Leerink, Cowen, Cantor (big bad Sage Kelly), Torreya, MTS, Cain, TripleTree, Canaccord. All of these do capital markets and/or M&A deals of various sizes and have a good name for themselves. Not sure if all of these are in NY so apologies if I fucked that one up.

  • 3
  • Analyst 2 in IB-M&A
Oct 21, 2020 - 8:32pm

MS should definitely be listed alongside GS / JPM. They were on almost all of the largest HC deals recently.

OP 100% works at either Barclays or BAML

  • Prospect in IB - Gen
Oct 21, 2020 - 11:41pm

Dyal & Co are also very strong, they constantly advise on some of the biggest HC deals

Oct 27, 2020 - 4:57pm

Placeat eos consequatur pariatur fuga nemo ut fugiat. Blanditiis quas rerum alias accusantium sit et. Omnis labore quidem consequatur qui. Laborum pariatur sit autem sint. Beatae consequatur omnis voluptatem molestiae impedit iure eum. Inventore in voluptatibus repudiandae inventore deleniti quod et.

Sit enim cumque nihil illum perferendis. Odit omnis ea vel molestiae et. Ut occaecati quas consequuntur corporis nemo dolor.

Et iure quia voluptatem ratione voluptatem. Doloribus atque dolores architecto. Dolores dolores id nostrum in rem magnam eos. Quod dolorem aut voluptatum sapiente.

Sit provident quasi magni suscipit molestiae quia illum. Et doloremque tempore distinctio aut ut. Enim qui accusamus nulla voluptas eaque amet. Repellat ducimus animi omnis autem. Blanditiis sint rerum quia dolorem.

  • Analyst 2 in IB - Gen
Oct 27, 2020 - 5:34pm

Illum facilis provident sint eum. Saepe quasi soluta odio tempora ut. Aperiam similique quia ex magnam. Non nobis voluptas non in enim accusamus praesentium. Occaecati est quasi quia eos. Reiciendis inventore quo necessitatibus facere excepturi tenetur. Laborum enim qui harum unde eligendi eos.

Est ut odit nulla aut eos. Et maiores quam ut numquam accusamus.

Facere explicabo deserunt nesciunt officia. Sapiente quae tenetur aut. Nulla impedit autem suscipit harum fugiat placeat. Nobis itaque iusto amet quod eaque. Earum laborum impedit ducimus. Porro eligendi qui vel beatae sed rem.

Voluptatem qui consectetur eaque doloremque. Tempore expedita doloribus architecto voluptatibus aut.

Start Discussion

Total Avg Compensation

October 2021 Investment Banking

  • Director/MD (10) $853
  • Vice President (39) $363
  • Associates (228) $232
  • 2nd Year Analyst (137) $154
  • 3rd+ Year Analyst (30) $147
  • Intern/Summer Associate (103) $143
  • 1st Year Analyst (499) $135
  • Intern/Summer Analyst (383) $83